Retos de la vacunación contra covid y VSR, en Ecuador, para 2025

Ecuador faced spikes in major respiratory infections in 2024, with respiratory sinitis virus (RSV) and SARS-CoV-2 being the most predominant.   

The virus Both affects the most vulnerable groups. In the case of RSV, it has a primary impact on children from 0 to New Year’s. Covid has a greater impact on all adults, older adults, and persistent chronic diseases. In other cases, there are hospitalizations and intensive care. As of December 14, 2024, the public fitness surveillance formula recorded 13,828 cases of covid and 42 falls due to this cause. So, although mortality is low compared to the pandemic, the accumulation of infections is significant. In 2022 and 2023, the cases shown will not exceed 2,000 each year.  

With this accumulation of covid cases, a constant presence of RSV and abundant post-covid security, the country’s vaccination and prevention strategy is being evaluated for 2025.  

La atención a estos dos problemas de salud requiere acciones y campañas de comunicación claras y efectivas, basadas en la evidencia científica. Con esto, además, se atacan los bulos de desinformación que se generaron en los dos últimos años. 

The returns are wonderful due to the fact that the population has had to get rid of so much emptiness. There are other people who sign up to increase their dose, but that’s where the severity of the brothers is reduced.

And, on the other hand, there is an anti-vaccine group, which is based on the wisdom of “safety immunity. ” But this coverage is low for a minor vaccination.   The vaccination figures for 2023 and 2024 constitute a vaccine fund.

In addition, priority is now given to threat groups, strategic sectors and front lines. We won the vaccine, from May to September 2024, for the only time. Currently, there are no Covid vaccines in public gyms.

Experts on the subject agree that they want to reevaluate this medication, they may require normal vaccination against covid and the only thing that happens is that there are cases throughout the entire year and, on average, in the winter season.  

National vaccination, as advised by the World Health Organization (WHO), must be adapted to the expressed wishes of the population, especially in times of high risk. In addition, it will be necessary to adapt to new variants and prioritize the most vulnerable groups.  

At this time, the acquisition of vaccines, via the revolving fund of the Pan American Health Organization (PAHO), is key. This mechanism does not make certain the availability of the dosage, yet also upper costs and biological products adapted to the wishes of the country. It is a must-have to make certain a well timed source of vaccines.  

Por otro lado, el VSR superó al covid como la infección respiratoria más prevalente en Ecuador en 2024. En países como Estados Unidos y México ya se cuenta con una vacuna contra el VSR, en Ecuador se espera su llegada en este 2025. 

La aplicación de este biológico en embarazadas, bebés y adultos mayores reduce las hospitalizaciones y las complicaciones graves, como ya sucede en otras naciones. 

Esta vacuna contra el VSR ya es parte del fondo rotatorio de la OPS por lo que resultaría más fácil incorporar al esquema nacional de vacunación. 

Tanto covid como VSR representan retos importantes para el sistema de salud en Ecuador. La vacunación sigue siendo la herramienta más efectiva para controlar estas enfermedades. Pero su implementación debe ser oportuna y debe adaptarse a las realidades locales.

Leave a Comment

Your email address will not be published. Required fields are marked *